Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.694 SEK | -3.34% | -5.45% | -4.93% |
20/02 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
20/02 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 22.41M 2.05M 171M | Sales 2022 | 12.8M 1.17M 97.53M | Capitalization | 120M 10.93M 911M |
---|---|---|---|---|---|
Net income 2021 | -200M -18.28M -1.52B | Net income 2022 | -160M -14.63M -1.22B | EV / Sales 2021 | 49.7 x |
Net cash position 2021 | 378M 34.53M 2.88B | Net cash position 2022 | 187M 17.06M 1.42B | EV / Sales 2022 | -5.24 x |
P/E ratio 2021 |
-5.8
x | P/E ratio 2022 |
-0.75
x | Employees | 3 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 62.57% |
1 day | -3.34% | ||
1 week | -5.45% | ||
Current month | -10.10% | ||
1 month | -8.44% | ||
3 months | +3.27% | ||
6 months | -12.04% | ||
Current year | -4.93% |
Managers | Title | Age | Since |
---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 72 | 09/01 |
Magnus Hurst
DFI | Director of Finance/CFO | 68 | 10/01 |
Roger Tell
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Erik Lind
CHM | Chairman | 83 | - |
Sten Nilsson
BRD | Director/Board Member | 76 | 04/01 |
Alain Herrera
BRD | Director/Board Member | 74 | 01/18/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.694 | -3.34% | 872,145 |
25/24/25 | 0.718 | +3.76% | 324,429 |
24/24/24 | 0.692 | -0.86% | 1,118,525 |
23/24/23 | 0.698 | -2.92% | 238,346 |
22/24/22 | 0.719 | -2.04% | 261,088 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:51 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-4.93% | 10.22M | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- ISOFOL Stock